Essential updates to the surgical treatment of biliary tract cancer

S Matsukuma, Y Tokumitsu, Y Shindo… - Annals of …, 2019 - Wiley Online Library
Biliary tract cancer, which includes intrahepatic cholangiocarcinoma, extrahepatic bile duct
cancer, gallbladder cancer, and ampullary cancer, is an intractable disease with a dismal …

Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

M Strijker, A Belkouz, LG van der Geest… - Acta …, 2019 - Taylor & Francis
Background: Population-based data on distal cholangiocarcinoma (DCC) from the Western
world are not available, albeit essential to identify areas for improvement. This study …

Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy-A …

L Bolm, K Ohrner, G Nappo, F Rückert, C Zimmermann… - Pancreatology, 2020 - Elsevier
Abstract Background/Objective The benefit of adjuvant therapy in ampullary cancer
(AMPAC) patients following pancreatoduodenectomy (PD) is debated. The aim of this study …

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy

C He, Y Mao, J Wang, F Duan, X Lin, S Li - BMC cancer, 2018 - Springer
Background The prognosis of patients with periampullary adenocarcinoma after
pancreatoduodenectomy is diverse and not yet clearly illustrated. The aim of this study was …

Systemic immune-inflammation index as a prognostic marker for distal cholangiocarcinoma

F Terasaki, T Sugiura, Y Okamura, T Ito, Y Yamamoto… - Surgery Today, 2021 - Springer
Purpose The systemic immune-inflammation index (SII) is a new marker, defined as the
platelet count× neutrophil-to-lymphocyte ratio. This study evaluates the SII as a prognostic …

[HTML][HTML] Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal …

L Bolm, E Petrova, J Weitz, F Rückert, UA Wittel… - HPB, 2019 - Elsevier
Background Distal cholangiocarcinoma (DCC) is a rare malignancy and validated
prognostic markers remain scarce. We aimed to evaluate the role of serum CA19-9 as a …

Indications for resection of recurrent lesions in patients with distal cholangiocarcinoma based on prognostic factors: a single-institute retrospective study and brief …

T Mashiko, T Ogasawara, Y Masuoka, S Ei… - BMC surgery, 2022 - Springer
Background To evaluate the effectiveness of surgery for recurrent distal cholangiocarcinoma
and determine surgical indications based on prognostic factors for the recurrence of distal …

Prognostic impact of margin status in distal cholangiocarcinoma

T Nakagohri, S Takahashi, S Ei, Y Masuoka… - World Journal of …, 2023 - Springer
Background A positive ductal margin is strongly associated with poor survival in patients
with distal cholangiocarcinoma. However, the significance of the radial margin status and its …

Development and validation of an online calculator to predict early recurrence and long‐term survival in patients with distal cholangiocarcinoma after …

S Xu, XP Zhang, GD Zhao, ZM Zhao… - Journal of Hepato …, 2022 - Wiley Online Library
Background Distal cholangiocarcinoma (DCC) is a malignancy associated with a short
survival time. In this study, we aimed to create an online nomogram calculator to predict …

Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma

O Beetz, M Klein, H Schrem, J Gwiasda, FWR Vondran… - BMC surgery, 2018 - Springer
Background Distal cholangiocarcinoma (DCC) is a rare but over the last decade increasing
malignancy and is associated with poor prognosis. According to the present knowledge …